spacer
home > pmps > summer 2002 > new manufacturing technologies - from drug discovery to final product
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

New Manufacturing Technologies - From Drug Discovery to Final Product

Anyone working within the life sciences industries knows that it takes significant investments of time, human and monetary resources to bring a new drug from discovery to the finished goods state. During the last decade, average times for this process peaked at 15 years from inception to launch. During that time, all pharmaceutical firms worked aggressively to reduce the time to develop and market, and the late 1990s saw dramatic reductions (some as much as 40 per cent, but on average, reductions took the process from 15 years to around nine to 10 years).

The industry was once quite unique in its record of business success. With high growth rates, barriers to entry and profits, the pharmaceutical industry was recognised as one of the most successful business spaces in the world marketplace. Recent years, however, have seen the industry running up against a number of unforeseen changes in the manufacturing life cycle.

These changes have inhibited the development, marketing and eventual sales of new drugs, and have increased potential risks and the costs associated with them. Similar changes have taken place across the breadth of life sciences manufacturing, extending beyond pharmaceuticals to nutraceuticals/ dietary supplements, to clinical and biotech manufacturing, resulting in heightened risk, threats to agility, challenges in enterprise-wide collaboration, and impaired time to market.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Benjamin Bryant, Global Communications, at Honeywell Industry Solutions for Chemicals, Life Sciences and Consumer Goods Benjamin Bryant co-ordinates global communications for Honeywell's Chemicals, Life Sciences, and Consumer Goods business, his employer since 2000, when he represented the POMS business exclusively. Prior appointments include service as well-known radio and news presenter in Austin, Texas, and work for the United States Army & Exchange Service in merchandising and promotions.
Benjamin is a member of the Association of the United States Army and the Public Relations Society of America, where he serves on the 12-member executive board of the society's international section. He has attended the University of Texas and the business programme at the University of Phoenix.

spacer
Benjamin Bryant
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PharmaFluidics awarded VLAIO research grant

Ghent, Belgium – June 2, 2020 PharmaFluidics NV, innovative player in the field of analytical chromatography with its unique high-resolution µPAC™ micro-Chip technology, announces that it has been awarded a € 613 k grant from Flanders’ Innovation & Entrepreneurship Agency (VLAIO). The grant will run over two years and will support the further optimization of PharmaFluidics’ manufacturing flow, and to develop complementary new surface-modified µPAC™ products.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement